IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Teva Pharmaceutical FIN LLC

CUSIP: 88163VAE9 | 173 institutional holders

Quarters

Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2022

Income Research & Management12,028,000
4.5% of portfolio›$9.6K
Wellington Management Group LLP10,000,000
0.0% of portfolio›$8.0K
HighTower Advisors, LLC38,000
0.0% of portfolio›$30
Commonwealth Equity Services, LLC11,000
0.0% of portfolio›$8
Creative Planning10,000
0.0% of portfolio›$10
Morgan Stanley6,000
0.0% of portfolio›$5
Wells Fargo & Company5,000
0.0% of portfolio›$4
Bank of America Corp3,000
0.0% of portfolio›$2
American Portfolios Advisors2,000
0.0% of portfolio›$1.6K
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Income Research & Management
12,028,000$9.6K4.5%N/AN/ABoston, MA2022-10-20
Wellington Management Group LLP
10,000,000$8.0K0.0%CoreMediumBoston, MA2022-11-14
HighTower Advisors, LLC
38,000$300.0%IndexLowChicago, IL2022-11-09
Commonwealth Equity Services, LLC
11,000$80.0%ETFLowWaltham, MA2022-11-14
Creative Planning
10,000$100.0%IndexVery LowOverland Park, KS2022-11-03
Morgan Stanley
6,000$50.0%CoreLowNew York, NY2022-11-14
Wells Fargo & Company
5,000$40.0%CoreLowSan Francisco, CA2022-11-14
Bank of America Corp
3,000$20.0%CoreLowCharlotte, NC2022-11-14
American Portfolios Advisors
2,000$1.6K0.0%N/AN/AHolbrook, NY2023-03-17
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2022-11-15